Related Experiment Video
Updated: Jul 18, 2026

Detection of Glycosaminoglycans by Polyacrylamide Gel Electrophoresis and Silver Staining
Published on: February 25, 2021
Anticoagulant heparan sulfate: structural specificity and biosynthesis
1Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina, Rm 309, Beard Hall, Chapel Hill, NC 27599, USA. jian_liu@unc.edu
Heparan sulfate (HS), a complex polysaccharide, regulates blood vessel functions. Understanding HS biosynthesis and its interactions with coagulation factors aids in developing novel anticoagulant therapies.
Area of Science:
- Biochemistry and Medicinal Chemistry
- Molecular Biology and Pharmacology
Background:
- Heparan sulfate (HS) is a highly sulfated polysaccharide abundant on endothelial cell surfaces.
- HS plays critical roles in regulating blood vessel wall functions, including coagulation and inflammation.
- Heparin, an HS analog, is a widely used anticoagulant, highlighting HS's therapeutic potential.
Purpose of the Study:
- To review recent advancements in understanding heparan sulfate interactions with blood-coagulating factors.
- To summarize progress in the biosynthesis of anticoagulant HS and its enzymes.
- To explore novel enzymatic synthesis approaches for HS and its therapeutic applications.
Main Methods:
- Review of current literature on heparan sulfate structure-function relationships.
- Analysis of studies on heparan sulfate biosynthesis pathways and enzyme mechanisms.
- Examination of novel strategies for synthesizing HS from bacterial polysaccharides.
Main Results:
- Detailed insights into the specific sequences of HS that dictate its biological functions.
- Elucidation of the mechanisms employed by HS biosynthetic enzymes.
- Demonstration of enzymatic approaches to synthesize specific HS structures from bacterial precursors.
Conclusions:
- Understanding HS biosynthesis is key to developing targeted anticoagulant therapies.
- Enzymatic synthesis offers a promising route to produce specific HS structures for therapeutic use.
- These advancements lay the groundwork for novel polysaccharide-based therapeutic agents.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Proteoglycans
Venous Thrombosis III: Interprofessional Care

